Variant report
Variant | esv3410896 |
---|---|
Chromosome Location | chr6:81329433-81332556 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539482780 | chr6:81329449-81329450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs57562574 | chr6:81329460-81329461 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs2496683 | chr6:81329501-81329502 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs555549267 | chr6:81329502-81329503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148121509 | chr6:81329508-81329509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541346056 | chr6:81329509-81329510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571078414 | chr6:81329571-81329572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551462852 | chr6:81329615-81329616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7774812 | chr6:81329659-81329660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532928205 | chr6:81329671-81329672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543081934 | chr6:81329675-81329676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563396262 | chr6:81329733-81329734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529041253 | chr6:81329813-81329814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538422664 | chr6:81329822-81329823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549160342 | chr6:81329858-81329859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs28524518 | chr6:81329912-81329913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141883367 | chr6:81329917-81329918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528368140 | chr6:81329927-81329928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551669950 | chr6:81329974-81329975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556868417 | chr6:81329986-81329987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150775237 | chr6:81329992-81329993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549226316 | chr6:81330013-81330014 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183935509 | chr6:81330068-81330069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539817286 | chr6:81330087-81330088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188664878 | chr6:81330100-81330101 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181272464 | chr6:81330137-81330138 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114689421 | chr6:81330154-81330155 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367564029 | chr6:81330169-81330170 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139131099 | chr6:81330193-81330194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149536709 | chr6:81330222-81330223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534938536 | chr6:81330258-81330259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558411357 | chr6:81330293-81330294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs578262602 | chr6:81330304-81330305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572482204 | chr6:81330330-81330331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543398390 | chr6:81330334-81330335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563284376 | chr6:81330337-81330338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554501513 | chr6:81330339-81330340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572860003 | chr6:81330346-81330347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2444805 | chr6:81330350-81330351 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs538406893 | chr6:81330355-81330356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560010143 | chr6:81330417-81330418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376999730 | chr6:81330432-81330433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533594066 | chr6:81330485-81330486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs76697441 | chr6:81330527-81330528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545605353 | chr6:81330539-81330540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200279440 | chr6:81330586-81330587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201515144 | chr6:81330587-81330588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528272509 | chr6:81330593-81330594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551701211 | chr6:81330602-81330603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76493950 | chr6:81330620-81330621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:81328600-81329600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr6:81329000-81329600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr6:81329000-81330000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:81329200-81332000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr6:81329600-81332200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr6:81330000-81330200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr6:81331000-81332000 | Weak transcription | Adipose Nuclei | Adipose |
8 | chr6:81332000-81332200 | Enhancers | Adipose Nuclei | Adipose |
9 | chr6:81332000-81333000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr6:81332200-81332400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr6:81332200-81332600 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
12 | chr6:81332200-81332600 | Enhancers | Lung | lung |
13 | chr6:81332200-81332800 | Flanking Active TSS | Adipose Nuclei | Adipose |
14 | chr6:81332200-81332800 | Enhancers | Liver | Liver |
15 | chr6:81332200-81332800 | Enhancers | Left Ventricle | heart |
16 | chr6:81332200-81333000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
17 | chr6:81332200-81333000 | Enhancers | HMEC | breast |
18 | chr6:81332200-81333600 | Enhancers | HSMMtube | muscle |
19 | chr6:81332200-81333800 | Enhancers | HSMM | muscle |
20 | chr6:81332400-81332800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |